D2 partial agonists for relapse prevention in schizophrenia - the long-term view

被引：0
|
作者：
Correll, C. U. [1 ,2 ]
机构：
[1] Zucker Hillside Hosp, Hofstra North Shore LIJ Sch Med, Psychiat, Glen Oaks, NY USA
[2] Zucker Hillside Hosp, Recognit & Prevent Program, Glen Oaks, NY USA
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2019年 / 29卷
关键词：
ARIPIPRAZOLE;
D O I：
10.1016/j.euroneuro.2018.11.998
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
C.13.05
引用
下载
收藏
页码：S630 / S630
页数：1
相关论文
共 50 条
  • [41] RELAPSE PREVENTION - AN EMERGING TECHNOLOGY FOR PROMOTING LONG-TERM DRUG ABSTINENCE
    DEJONG, W
    INTERNATIONAL JOURNAL OF THE ADDICTIONS, 1994, 29 (06): : 681 - 705
  • [42] PREVENTION OF RELAPSE IN DUODENAL ULCERATION BY LONG-TERM NOCTURNAL METIAMIDE TREATMENT
    THOMPSON, MH
    VENABLES, CW
    GUT, 1976, 17 (05) : 389 - 389
  • [43] Long-term relapse prevention: A stratified dose comparison of risperidone and haloperidol
    Vangeneugden, T
    Augustyns, I
    Curinckx, H
    Ingham, M
    Mahmoud, R
    SCHIZOPHRENIA RESEARCH, 2002, 53 (03) : 175 - 176
  • [44] Long-term results of curative (D2) resection for adenocarcinoma of gastric cardia
    Kobayashi, O
    Suzuki, K
    Ishii, H
    Takahashi, M
    Onodera, S
    Okugawa, T
    Rino, Y
    Tsuburaya, A
    Yamamoto, Y
    Sairenji, M
    Motohashi, H
    PROGRESS IN GASTRIC CANCER RESEARCH 1997: PROCEEDINGS OF THE 2ND INTERNATIONAL GASTRIC CANCER CONGRESS, 1997, : 1723 - 1726
  • [45] MGLUR2 AGONISTS FOR RELAPSE PREVENTION
    Spanagel, R.
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2014, 38 : 338A - 338A
  • [46] Double-blind, placebo-controlled trial of asenapine in prevention of relapse after long-term treatment of schizophrenia
    Mackle, M.
    Snow-Adami, L.
    Zhao, J.
    Szegedi, A.
    Panagides, J.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2009, 19 : S543 - S543
  • [47] Long-term cariprazine treatment for the prevention of relapse in patients with schizophrenia: a double-blind, placebo-controlled trial
    Durgam, S.
    Earley, W.
    Li, R.
    Li, D.
    Lu, K.
    Laszlovszky, I.
    Fleischhacker, W. W.
    Lieberman, J. A.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2015, 25 : S512 - S513
  • [48] Double-blind, placebo-controlled trial of asenapine in prevention of relapse after long-term treatment of schizophrenia
    Kane, J. M.
    Mackle, M.
    Snow-Adami, L.
    Zhao, J.
    Szegedi, A.
    Panagides, J.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2010, 13 : 223 - 223
  • [49] Association analysis of dopamine D2 receptor genetic variants and tardive dyskinesia in schizophrenia following long-term antipsychotic treatment
    Liou, YJ
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2005, 15 : S476 - S477
  • [50] A LONG-TERM VIEW
    HUNT, BB
    JOURNAL OF FORESTRY, 1993, 91 (10) : 4 - 4
12345